Evidence map›Paper›PMID 23082228›Full record

ArticlePloS one2012

The novel cis-encoded small RNA h2cR is a negative regulator of hfq2 in Burkholderia cenocepacia.

Christian G Ramos, Paulo J P da Costa, Gerd Döring, Jorge H Leitão

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Small Noncoding Regulatory RNAs fromInternational journal of molecular sciences · 2018
    Review
  4. The Roles of TwoThe plant pathology journal · 2018
    Article
  5. Genetic Determinants Associated WithFrontiers in microbiology · 2018
    Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Christian G RamosInstitute for Biotechnology and Bioengineering, Instituto Superior Técnico, Universidade Técnica de Lisboa, Lisboa, Portugal.
Paulo J P da Costa
Gerd Döring
Jorge H Leitão
Institute for Biotechnology and Bioengineering · PTInstituto Politécnico de Lisboa · PTUniversity of Tübingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Small non-coding regulatory RNAs (sRNAs) post-transcriptionally affect multiple phenotypes in prokaryotes and eukaryotes, yet most of the underlying regulatory mechanisms and the nature of the target mRNAs remain unclear. Here we report the identification and functional analysis of the novel cis-encoded sRNA h2cR, from the human opportunistic pathogen Burkholderia cenocepacia J2315. The sRNA was found to negatively regulate the hfq2 mRNA, through binding to part of the 5'-UTR region of the hfq2 mRNA, resulting in accelerated hfq2 mRNA decay and reduced protein levels in exponentially growing cells. Both the h2cR transcript and the hfq2 mRNA are stabilized by the other B. cenocepacia RNA chaperone, Hfq. Infection experiments using the nematode Caenorhabditis elegans revealed that down-regulation of Hfq2 by h2cR decreases the B. cenocepacia ability to colonize and persist within the nematode, suggesting a role for h2cR on bacterial persistence in the host.

Indexed as

5' Untranslated RegionsAnimalsBacterial ProteinsBase SequenceBurkholderia cenocepaciaCaenorhabditis elegansCloning, MolecularColony Count, MicrobialGene Expression Regulation, BacterialGene SilencingGenome, BacterialHumansMolecular Sequence DataProtein BindingRNA, BacterialRNA, Messenger5' Untranslated RegionsBacterial ProteinsRNA, BacterialRNA, Messenger

Identifiers

PMID23082228
PMCPMC3474761
OpenAlexW2037593450

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.